| Trading Statement | 07-Nov-2025 | 07:00 | RNS |
| Director Declaration | 05-Nov-2025 | 14:45 | RNS |
| Completion of OrthoLite acquisition | 30-Oct-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 20-Oct-2025 | 12:41 | RNS |
| Holding(s) in Company | 17-Oct-2025 | 13:42 | RNS |
| Block listing Interim Review | 06-Oct-2025 | 13:06 | RNS |
| Director Declaration | 16-Sep-2025 | 14:00 | RNS |
| Holding(s) in Company | 12-Sep-2025 | 15:22 | RNS |
| Holding(s) in Company | 11-Sep-2025 | 15:13 | RNS |
| Director/PDMR Shareholding | 10-Sep-2025 | 13:09 | RNS |
| Holding(s) in Company | 03-Sep-2025 | 12:58 | RNS |
| Holding(s) in Company | 11-Aug-2025 | 11:03 | RNS |
| Holding(s) in Company | 05-Aug-2025 | 10:44 | RNS |
| Total Voting Rights | 31-Jul-2025 | 12:39 | RNS |
| Further Information re Acquisition of OrthoLite | 29-Jul-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 80.80p |
| Change Today | 0.30p |
| % Change | 0.37 % |
| 52 Week High | 96.40p |
| 52 Week Low | 68.20p |
| Volume | 945,191 |
| Shares Issued | 1,917.37m |
| Market Cap | £1,549.24m |
| RiskGrade | 39 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 2 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 16-Oct-25 | 01-May-25 |
| Paid | 13-Nov-25 | 29-May-25 |
| Amount | 1.00¢ | 2.19¢ |
| Time | Volume / Share Price |
| 16:00 | 3 @ 80.70p |
| 15:32 | 15 @ 80.60p |
| 15:08 | 6 @ 80.20p |
| 16:46 | 5,896 @ 80.80p |
| 15:01 | 1 @ 80.40p |
| Chair | David Gosnell |
| CEO | David Paja |
| CFO | Hannah Nichols |
You are here: research